Literature DB >> 16778561

Oxidative metabolism in cancer growth.

Michael Ristow1.   

Abstract

PURPOSE OF REVIEW: Recent evidence suggests that oxidative metabolism may have a key role in controlling cancer growth. This review will provide an overview of the evidence accumulated so far. More than 80 years ago, Otto Warburg suggested that impaired oxidative metabolism may cause malignant growth. This assumption, later known as Warburg's hypothesis, has been experimentally addressed for many decades. It employs multiple approaches including cell lines, implanted xenografts and other animal models, by biochemical methods to quantify glycolytic and mitochondrial fluxes and signaling pathways including the rates of intermediate metabolism, respiration and oxidative phosphorylation. RECENT
FINDINGS: The hallmarks of cancer growth, increased glycolysis and lactate production in tumors, have raised attention recently due to novel observations suggesting a wide spectrum of oxidative phosphorylation deficits and decreased availability of ATP associated with malignancies and tumor cell expansion. The most recent findings suggest that forcing cancer cells into mitochondrial metabolism efficiently suppresses cancer growth, and that impaired mitochondrial respiration may even have a role in metastatic processes.
SUMMARY: This review summarizes published evidence on the essential interaction of tumor growth and mitochondrial metabolism, implicating novel approaches for the prevention and treatment of malignant disease.

Entities:  

Mesh:

Year:  2006        PMID: 16778561     DOI: 10.1097/01.mco.0000232892.43921.98

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  43 in total

1.  Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity.

Authors:  Doreen Pomplun; Anja Voigt; Tim J Schulz; René Thierbach; Andreas F Pfeiffer; Michael Ristow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

Review 2.  Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms.

Authors:  Thomas E Gunter; Shey-Shing Sheu
Journal:  Biochim Biophys Acta       Date:  2009-01-06

3.  Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.

Authors:  Muthusamy Thangaraju; Senthil K Karunakaran; Shiro Itagaki; Elangovan Gopal; Selvakumar Elangovan; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

4.  Rapamycin increases mitochondrial efficiency by mtDNA-dependent reprogramming of mitochondrial metabolism in Drosophila.

Authors:  Eugenia Villa-Cuesta; Marissa A Holmbeck; David M Rand
Journal:  J Cell Sci       Date:  2014-03-07       Impact factor: 5.285

5.  Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines.

Authors:  Rajaa Hussien; George A Brooks
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

6.  Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.

Authors:  Ana P D Demasi; Ana F Costa; Albina Altemani; Cristiane Furuse; Ney S Araújo; Vera C Araújo
Journal:  Int J Exp Pathol       Date:  2010-01-21       Impact factor: 1.925

Review 7.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

8.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

9.  Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism.

Authors:  Helene Pelicano; Weiqin Lu; Yan Zhou; Wan Zhang; Zhao Chen; Yumin Hu; Peng Huang
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 10.  Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.

Authors:  Tamás Deli; László Csernoch
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.